P
ProKidney Corp D
D
PROK
1.50000
USD
-0.03
(-1.96%)
مغلق
حجم التداول
2,622
الربح لكل سهم
-0
العائد الربحي
-
P/E
-3
حجم السوق
191,952,365
المقالات
العنوان: ProKidney Corp
القطاع: Healthcare
الصناعة: Biotechnology
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.